In contrast, in esophageal squamous cell carcinoma, gastric cancer, colorectal cancer, and breast cancer, increased expression of FSTL1 is associated with a poor prognosis [55,56,57,58]. This evidence concerns the gene FSTL1 and gastric cancer.